SPA-Public Admin and Policy
4400 Massachusetts Avenue NW
Washington, DC 20016
Information about this author at RePEc
NBER Working Papers and Publications
|September 2009||A Cure for Crime? Psycho-Pharmaceuticals and Crime Trends|
with Sara Markowitz: w15354
In this paper we consider possible links between the advent and diffusion of a number of new psychiatric pharmaceutical therapies and crime rates. We describe recent trends in crime and review the evidence showing mental illness as a clear risk factor both for criminal behavior and victimization. We then briefly summarize the development of a number of new pharmaceutical therapies for the treatment of mental illness which diffused during the "great American crime decline." We examine limited international data, as well as more detailed American data to assess the relationship between crime rates and rates of prescriptions of the main categories of psychotropic drugs, while controlling for other factors which may explain trends in crime rates. We find that increases in prescriptions for psy...
Published: Dave E. Marcotte & Sara Markowitz, 2011. "A cure for crime? Psycho‐pharmaceuticals and crime trends," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 30(1), pages 29-56, December. citation courtesy of
|February 2007||Anti-depressants and Suicide|
with Jens Ludwig, Karen Norberg: w12906
Does drug treatment for depression with selective serotonin reuptake inhibitors (SSRIs) increase or decrease the risk of completed suicide? The question is important in part because of recent government warnings that question the safety of SSRIs, one of the most widely prescribed medications in the world. While there are plausible clinical and behavioral arguments that SSRIs could have either positive or negative effects on suicide, randomized clinical trials have not been very informative because of small samples and other problems. In this paper we use data from 26 countries for up to 25 years to estimate the effect of SSRI sales on suicide mortality using just the variation in SSRI sales that can be explained by cross-country variation in the growth of drug sales more generally. We ...
Published: Ludwig, Jens & Marcotte, Dave E. & Norberg, Karen, 2009.
"Anti-depressants and suicide,"
Journal of Health Economics,
Elsevier, vol. 28(3), pages 659-676, May.
citation courtesy of